|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61P 25/00 | (2006.01) |
| A01N 43/42 | (2006.01) | ||
| A61K 31/4704 | (2006.01) | ||
| A61K 31/136 | (2006.01) | ||
| A61K 38/16 | (2006.01) | ||
| A61K 45/06 | (2006.01) |
| (11) | Number of the document | 2442651 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10789873.6 |
| Date of filing the European patent application | 2010-06-18 | |
| (97) | Date of publication of the European application | 2012-04-25 |
| (45) | Date of publication and mention of the grant of the patent | 2015-07-29 |
| (46) | Date of publication of the claims translation | 2015-11-25 |
| (86) | Number | PCT/US2010/001759 |
| Date | 2010-06-18 |
| (87) | Number | WO 2010/147665 |
| Date | 2010-12-23 |
| (30) | Number | Date | Country code |
| 269070 P | 2009-06-19 | US |
| (72) |
TARCIC, Nora, IL
BAR-ZOHAR, Dan, IL
KOFLER, Dina, IL
|
| (73) |
Teva Pharmaceutical Industries Ltd.,
5 Basel Street P.O. Box 3190, 49131 Petah Tiqva,
IL
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Išsėtinės sklerozės gydymas lakvinimodu |
| TREATMENT OF MULTIPLE SCLEROSIS WITH LAQUINIMOD |
| Payment date | Validity (years) | Amount | |
| 2017-05-29 | 8 | 185.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2018-06-18 |